EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Hepatoprotective potential of medicinal plants of Kazakhstan: a review

Alibek Ydyrys

Natural Resources for Human Health · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Liver diseases represent a significant global health challenge, underscoring the need for safe and effective hepatoprotective agents from natural sources. Kazakhstan’s rich and diverse flora provides numerous medicinal plants traditionally used for liver ailments. This review evaluates the hepatoprotective potential of seven Kazakhstani species Glycyrrhiza glabra, Glycyrrhiza uralensis, Silybum marianum, Berberis heteropoda, Artemisia absinthium, Arctium lappa, and Arctium tomentosum focusing on their phytochemical composition, pharmacological mechanisms, and experimental evidence. Special attention is given to their efficacy in models of chemically induced hepatotoxicity, particularly carbon tetrachloride (CCl₄), as well as their anti-inflammatory and antifibrotic activities, highlighting their promise as sources of novel hepatoprotective agents. The reviewed Kazakhstani plants demonstrate substantial hepatoprotective activity through multiple complementary mechanisms. Glycyrrhiza species, rich in glycyrrhizin and glabridin, exert anti-inflammatory and antioxidant effects, mitigating hepatic steatosis and fibrosis in CCl₄-induced liver injury models. Silybum marianum, a primary source of silymarin, stabilizes hepatocyte membranes, promotes liver regeneration, and normalizes serum enzyme levels. Berberis heteropoda, containing berberine, protects against toxin-induced hepatic damage by modulating oxidative stress and apoptosis. Artemisia absinthium and both Arctium species display strong antioxidant potential, reducing malondialdehyde (MDA) levels and restoring endogenous antioxidant enzyme activity. Collectively, these findings indicate that the hepatoprotective properties of these plants are largely mediated through the suppression of oxidative stress and inflammation, key drivers of liver pathology. These results highlight the therapeutic potential of Kazakhstan’s medicinal flora as a source of novel hepatoprotective agents and emphasize the need for further phytochemical, pharmacological, and clinical investigations to validate traditional uses.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Alibek Ydyrys
Quelle
Natural Resources for Human Health
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
2583-1194
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Alibek Ydyrys (2026). Hepatoprotective potential of medicinal plants of Kazakhstan: a review. Natural Resources for Human Health. https://doi.org/10.53365/nrfhh/224634
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1